A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage

NCT05970224 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Intracerebral Hemorrhage

Interventions

DRUG: Ir-CPI

Sponsor

Bioxodes S.A.